Evidence map›Paper›PMID 41872586›Full record

ReviewNPJ cardiovascular health2026

Precision percutaneous coronary intervention.

Travis M Wilson, Uzair Munaf, Nafhat Shaikh, Affan Rizwan, Riyan Siddiqui, Hafeez Ul Hassan Virk, Mahboob Alam, Umair Khalid, Muzamil Khawaja, Tanawat Attachaipanich and 7 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in NPJ cardiovascular health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Travis M WilsonDepartment of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Uzair MunafDepartment of Internal Medicine, University of Mississippi Medical Center, Atlanta, GA, USA.
Nafhat ShaikhDepartment of Medicine, Liaquat University of Medical & Health sciences, Jamshoro, Pakistan.
Affan RizwanDepartment of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.
Riyan SiddiquiDepartment of Internal Medicine, University of Mississippi Medical Center, Atlanta, GA, USA.
Hafeez Ul Hassan VirkHarrington Heart & Vascular Institute, Case Western Reserve University, University Hospitals, Cleveland Medical Center, Cleveland, OH, USA.
Mahboob AlamThe Texas Heart Institute, Baylor College of Medicine, Houston, TX, USA.
Umair KhalidMichael E. DeBakey VA Medical Center, Section of Cardiology, Baylor College of Medicine, Houston, TX, USA.
Muzamil KhawajaDepartment of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.
Tanawat AttachaipanichDepartment of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Larisa H CavallariDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, University of Florida College of Pharmacy, Gainesville, FL, USA.
Tania AhujaDepartment of Pharmacy, NYU Langone Health, NYU Grossman School of Medicine, New York, NY, USA.
Michael G NannaDepartment of Medicine, Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA.
Samin K SharmaCardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Hospital, New York, NY, USA.
Lloyd W KleinDepartment of Medicine, Section of Cardiology, University of California San Francisco, San Francisco, CA, USA.
Gary S MintzCardiovascular Research Foundation, New York, NY, USA.
Chayakrit KrittanawongHumanX, Delaware, DE, USA. chayakrit.krittanawong@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precision-based percutaneous coronary intervention (PCI) integrates contemporary strategies across the pre-, intra-, and post-procedural phases to improve outcomes and minimize complications. Emerging evidence underscores the value of these strategies in reducing adverse events and improving procedural efficiency. While artificial intelligence and pharmacogenomics hold long-term promise for enhancing personalization, their clinical utility in PCI remains in the early stages of development.

Identifiers

PMID41872586
PMCPMC13009385

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.